Low Dose Interleukin-2 for Refractory Autoimmune Hepatitis

Hepatology - United States
doi 10.1002/hep.30059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2

Current Diabetes Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Autoimmune Hepatitis and Juvenile Systemic Lupus Erythematosus: 2 for 1?

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Are High-Dose Steroids Really Necessary in Treatment of Autoimmune Hepatitis?

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Low Dose Combination Steroids Control Autoimmune Mouse Hearing Loss

Journal of Neuroimmunology
AllergyImmunologyNeurology
2010English

Refractory Ocular Behçet’s Disease; Outcome of Low Dose Infliximab

Rheumatology Research
2019English

Novel Immunotherapies for Autoimmune Hepatitis

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2017English

Low-Dose Docetaxel in Combination With Dexamethasone for Hormone-Refractory Prostate Cancer

Japanese Journal of Urology
Urology
2011English

Autoimmune Hepatitis.

Internal Medicine
Internal MedicineMedicine
1993English

NCI 8628: A Randomized Phase 2 Study of Ziv-Aflibercept and High-Dose Interleukin 2 or High-Dose Interleukin 2 Alone for Inoperable Stage III or IV Melanoma

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy